Physician
Hematology
Dr. Donald B. Wender, MD
|
|
Give Review
Donald B. Wender is an expert in the field of Hematology. He went to medical school at The Ohio State University College of Medicine. Donald Wender is a published doctor and has 19 publications published. The lastest was: 'Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.' Doctor Donald B. Wender, MD accepts Medicare.
Publications
- Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1.
- Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon Cancer: NCCTG N04C7.
- Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treat...
- Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
- Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung Cancer: A North C...
- A placebo-controlled double blind trial of etanercept for the Cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
- Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung Cancer (NCCTG 95-20-53).
- Randomized controlled trial to evaluate transdermal testosterone in female Cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
- Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherap...
- Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
- Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
- Inhibition of 5-fluorouracil-induced ocular irritation by ocular ice packs.
- Phase II trial of irinotecan in patients with metastatic coloRectal carcinoma.
- Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in Cancer patients.
- Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung Cancer.
- The prevalence of weight concerns in a smoking abstinence clinical trial.
- A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung Cancer: North Central Cancer Treatment Group Study N0326.
- Topotecan and paclitaxel in previously treated patients with relapsed small cell lung Cancer: phase II trial of the North Central Cancer Treatment Group.
Schools
Oh State Univ Coll Of Med and Pub Hlth
University Of Pittsburgh
University Health Center Of Pittsburgh
University Of Pittsburgh Med Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
University of Pittsburgh Medical Center -
The Ohio State University College of Medicine
Drug Facts
| NPI NUMBER | 1861463275 | |
| NPPES Provider LastName | WENDER | |
| NPPES Provider FirstName | DONALD | |
| NPPES Provider ZIPCode | 511011733 | |
| NPPES Provider State | IA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1957.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 146.0 | |
| Percent Opioid Claims | 7.46 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861463275 |
| Last Name Of The Provider | WENDER |
| First Name Of The Provider | DONALD |
| View All |
Similar Doctors
|
Dr. Magdy M. Elsawy, MD
 This Doctor is OpenDoctor Recommended.
|